APA (7th ed.) Citation

Danese, S., Subramaniam, K., Van Zyl, J., & Adsul, S. (2021). Editorial: Vedolizumab in inflammatory bowel diseases—less is more? Authors' reply. Alimentary Pharmacology & Therapeutics, 53(3), 445. https://doi.org/10.1111/apt.16227

Chicago Style (17th ed.) Citation

Danese, Silvio, Kavitha Subramaniam, Jan Van Zyl, and Shashi Adsul. "Editorial: Vedolizumab in Inflammatory Bowel Diseases—less Is More? Authors' Reply." Alimentary Pharmacology & Therapeutics 53, no. 3 (2021): 445. https://doi.org/10.1111/apt.16227.

MLA (9th ed.) Citation

Danese, Silvio, et al. "Editorial: Vedolizumab in Inflammatory Bowel Diseases—less Is More? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 53, no. 3, 2021, p. 445, https://doi.org/10.1111/apt.16227.